Sign In
Buy KVUE
$16.83
-0.490 (-2.83%)
At Close: Jun 03, 2026
Johnson & Johnson aims to raise $3 billion in Kenvue IPO
05:02pm, Monday, 24'th Apr 2023
Johnson & Johnson JNJ expects to raise roughly $3 billion in an initial public offering of its consumer-health unit. In a filing with the Securities and Exchange Commission made public Monday afternoo
Kenvue ‘will certainly be a beacon and a bellwether' for corporate spinouts, professor says
01:15pm, Monday, 24'th Apr 2023
Columbia University Healthcare Policy Professor Meghan Fitzgerald joins Yahoo Finance Live to discuss the expectations for health care earnings, health care trends, investor sentiment, and the outlook
U.S. IPO Weekly Recap: IPO Market Has A Full Week Of Small Deals, Led By Chinese Issuers
01:07am, Monday, 24'th Apr 2023
U.S. IPO Weekly Recap: IPO Market Has A Full Week Of Small Deals, Led By Chinese Issuers.
Johnson & Johnson plans to spin off consumer health business as Kenvue
07:19pm, Tuesday, 18'th Apr 2023
Yahoo Finance health care reporter Anjalee Khemlani joins the Live show to discuss Johnson & Johnson's plans to spinoff its consumer health business.
Johnson & Johnson looking at spinning off consumer health business as Kenvue
01:09pm, Tuesday, 18'th Apr 2023
#Johnson&Johnson Yahoo Finance's Anjalee Khemlani joins the Live show to discuss news that Johnson & Johnson is working toward spinning off its consumer health business as Kenvue.
Johnson & Johnson Preps for Kenvue Spinoff While Noting Strong Q1 in OTC
11:35am, Tuesday, 18'th Apr 2023
As Johnson & Johnson readies for the separation of its consumer health division later this year into the consumer-focused company called Kenvue, the healthcare giant's first quarter was marked by cont
U.S. IPO Weekly Recap: Small Deals Drive Activity In The IPO Market's Short Week
05:30am, Friday, 07'th Apr 2023
Four small issuers began trading this past week. Two small IPOs submitted initial filings.
J&J Kenvue spinoff adds slew of banks to its initial public offering roster
02:32pm, Monday, 06'th Mar 2023
Kenvue Inc., the consumer products spinoff from Johnson & Johnson JNJ, +0.89% , has grown the roster of banks underwriting its initial public offering beyond the two original leads . Goldman Sachs & C
Blue-Chip Stocks And Red Flags - Things To Consider In Your Due Diligence
11:35am, Wednesday, 18'th Jan 2023
Investing in blue-chip companies that pay dividends and relentlessly focusing on reinvesting the proceeds is a proven strategy for reliable long-term returns. But what about the occasional black swan?
J&J's Spin-Off Kenvue Lists for IPO in Healthcare Giant Split
10:35pm, Monday, 09'th Jan 2023
As markets open for the new year, a mega breakup that could shake up the consumer healthcare market is coming down the initial public offering (IPO) pipeline.
Kenvue Begins IPO Process As It Seeks To Separate From Johnson & Johnson
12:19am, Saturday, 07'th Jan 2023
Kenvue has filed to go public as part of its separation process from parent firm Johnson & Johnson. The company sells consumer healthcare and wellness products worldwide.
